Bristol-Myers Squibb

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$11,489,000
$12,502,000
$12,222,000
$12,269,000
Gross Profit
8,068,000
8,405,000
8,787,000
8,070,000
EBITDA
3,708,000
2,194,000
4,587,000
3,287,000
EBIT
3,271,000
1,368,000
3,594,000
2,258,000
Net Income
2,678,000
1,086,000
2,201,000
1,310,000
Net Change In Cash
11,489,000
12,502,000
12,222,000
12,269,000
Free Cash Flow
757,000
1,604,000
5,991,000
3,556,000
Cash
9,574,000
10,209,000
15,726,000
12,599,000
Basic Shares
2,043,511
2,041,000
2,037,963
2,038,000

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$48,194,000
$48,300,000
$45,006,000
$46,159,000
Gross Profit
32,602,000
27,432,000
25,357,000
26,490,000
EBITDA
14,545,000
3,168,000
19,366,000
19,221,000
EBIT
10,685,000
-6,432,000
9,606,000
8,945,000
Net Income
7,053,000
-8,948,000
8,025,000
6,327,000
Net Change In Cash
48,194,000
48,300,000
45,006,000
46,159,000
Cost of Revenue
-4,958,000
Free Cash Flow
12,845,000
13,942,000
12,651,000
11,948,000
Cash
10,209,000
10,346,000
11,464,000
9,123,000
Basic Shares
2,041,000
2,027,000
2,078,000
2,146,000

Earnings Calls

QuarterEPS
2026-03-31
$1.31
2025-12-31
$0.53
2025-09-30
$1.63
2025-06-30
$1.46